Peripheral neuropathy and cognitive impairment associated with a novel monoallelic HARS variant
Open Access
- 24 May 2019
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 6 (6) , 1072-1080
Abstract
Background: A 49‐year‐old male presented with late‐onset demyelinating peripheral neuropathy, cerebellar atrophy, and cognitive deficit. Nerve biopsy revealed intra‐axonal inclusions suggestive of polyglucosan bodies, raising the suspicion of adult polyglucosan bodies disease (OMIM 263570).Methods and Results: While known genes associated with polyglucosan bodies storage were negative, whole‐exome sequencing identified an unreported monoallelic variant, c.397G>T (p.Val133Phe), in the histidyl‐tRNA synthetase (HARS) gene. While we did not identify mutations in genes known to be associated with polygucosan body disease, whole‐exome sequencing revealed an unreported monoallelic variant, c.397G>T in the histidyl‐tRNA synthetase (HARS) gene, encoding a substitution (Val133Phe) in the catalytic domain. Expression of this variant in patient cells resulted in reduced aminoacylation activity in extracts obtained from dermal fibroblasts, without compromising overall protein synthesis.Interpretation: Genetic variants in the genes coding for the different aminoacyl‐tRNA synthases are associated with various clinical conditions. To date, a number of HARS variant have been associated with peripheral neuropathy, but not cognitive deficits. Further studies are needed to explore why HARS mutations confer a neuronal‐specific phenotype.Keywords
Funding Information
- National Institute of General Medical Sciences (5R01GM054899-20)
This publication has 29 references indexed in Scilit:
- A Loss-of-Function Variant in the Human Histidyl-tRNA Synthetase (HARS) Gene is Neurotoxic In VivoHuman Mutation, 2012
- Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel DiseasesPLOS ONE, 2012
- Imaging protein synthesis in cells and tissues with an alkyne analog of puromycinProceedings of the National Academy of Sciences, 2011
- Dominant Intermediate Charcot-Marie-Tooth Disorder Is Not Due to a Catalytic Defect in Tyrosyl-tRNA SynthetaseBiochemistry, 2011
- Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot–Marie–Tooth neuropathyProceedings of the National Academy of Sciences, 2009
- The Role of Aminoacyl-tRNA Synthetases in Genetic DiseasesAnnual Review of Genomics and Human Genetics, 2008
- An Active Dominant Mutation of Glycyl-tRNA Synthetase Causes Neuropathy in a Charcot-Marie-Tooth 2D Mouse ModelNeuron, 2006
- Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathyNature Genetics, 2006
- Glycyl tRNA Synthetase Mutations in Charcot-Marie-Tooth Disease Type 2D and Distal Spinal Muscular Atrophy Type VThe American Journal of Human Genetics, 2003
- Corpora-amylacea and the family of polyglucosan diseasesBrain Research Reviews, 1999